New Product Planning, Associate Director (Denmark, Søborg)

Jobbeskrivelse
Placering
Søborg, Denmark

Jobkategori
Commercial Marketing

Ansøg nu

Join us as an Associate Director of New Product Planning, leading strategic initiatives within the ground-breaking CETA (Cardiovascular & Emerging Therapy Areas) at Novo Nordisk.

If you're ready to pioneer change and make a lasting impact, this is your chance to be at the forefront of innovation.

The position will be based in Copenhagen, but we are also open to candidates abroad, supporting them with relocation.

The position
As the Associate Director for New Product Planning in the Cardiorenal therapeutic area, you will be responsible for developing and maintaining portfolio strategies and Commercial Guidance to ensure the successful execution of Novo Nordisk’s strategies. This role involves overseeing the timely delivery of high-quality commercial outputs and leading the planning and execution of crucial team meetings related to early commercialization efforts. Additionally, you will be responsible for developing and updating business cases for late-stage portfolio projects and representing CETA Early Portfolio & Insights in pivotal governance interactions.

Some of your responsibilities will be to:

• Develop and update portfolio strategies and commercial guidance for assigned strategic areas in Cardiorenal.

• Ensure timely delivery of high-quality commercial outputs in alignment with the Global Project Framework.

• Plan and execute Cardiorenal Early Commercialisation Team meetings, aligning key commercial stakeholders across HQ, North America, and IO operations.

• Oversee the development and updating of business cases for late-stage portfolio projects, preparing for the Spring Review with CETA Senior Management.

• Lead the development of commercial deliverables for key development projects and represent CETA Early Portfolio & Insights in governance interactions with EDComm, PDCouncil, and DPPComm.

Qualifications

• Master’s/PhD in economics or business combined with extensive skills in natural science, OR Master’s/PhD in life science combined with strong commercial understanding.

• At least 7 years of relevant experience within pharmaceutical industry, working with the portfolio and launches. Would be valuable to have new product planning experience.

• Will be a plus to have experience working in a big pharmaceutical company, as well as some previous experience working from consultancy to pharma industry.

• You have extensive experience working with early stages.

• To have M&A and/or financial cases modelling experience will be an advantage.

As a person, you are someone with outstanding communication skills, adept at stakeholder management, and equipped with strong project management abilities.

You don’t need to bring experience in cardiovascular or kidney, but could be taken in consideration as a plus. To succeed in this role, you will need to be fluent in both written and spoken English.

About the Department
The Cardiovascular & Emerging Therapy Areas (CETA) EP&I team at Novo Nordisk provides strategic guidance for R&D and Commercial sectors in new disease areas, including Cardiovascular Disease, Chronic Kidney Disease, MASH & liver disease, and Alzheimer’s disease. This involves exploring new targets, modalities, and molecular formats like gene therapy and RNAi technologies. The team conducts advanced analyses such as disease segment opportunity mapping and peak sales analysis, requiring a high level of expertise. Specialized skills are essential, surpassing those needed for Novo Nordisk’s heritage areas. Employees within CETA EP&I require strong value chain expertise and a deep understanding of the pharmaceutical industry within the CETA disease areas.

Contact
For further information about position do not hesitate to contact Frank Daniel Mersebach, CETA Early Portfolio & Insights Vice President, at [email protected]

Deadline
Please apply before 5th August.

Please note that only applications in English will be considered. We will review applications on an ongoing basis, so we encourage you to apply as soon as possible.

You do not need to attach a cover letter to your application, but please include a few sentences about why you are applying in your resume or CV.

To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV.

Working at Novo Nordisk
Novo Nordisk is its people. We know that life is anything but linear and balancing what is important at different stages of our career is never easy. That’s why we make room for diverse life situations, always putting people first. We value our employees for the unique skills they bring to the table, and we work continuously to bring out the best in them. Working at Novo Nordisk is working toward something bigger than ourselves, and it’s a collective effort. Novo Nordisk relies on the joint potential and collaboration of its more than 50,000 employees. Together, we go further. Together, we’re life changing.

We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.

At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.